| 000 | 01895 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517201502.0 | ||
| 264 | 0 | _c20181002 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2018.01.064 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNamoto, Kenji | |
| 245 | 0 | 0 |
_aStructure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _c03 2018 |
||
| 300 |
_a906-909 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _a3C Viral Proteases |
| 650 | 0 | 4 |
_aAntiviral Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aCysteine Endopeptidases _xmetabolism |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacrocyclic Compounds _xchemical synthesis |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 |
_aRhinovirus _xdrug effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aViral Proteins _xantagonists & inhibitors |
| 700 | 1 | _aSirockin, Finton | |
| 700 | 1 | _aSellner, Holger | |
| 700 | 1 | _aWiesmann, Christian | |
| 700 | 1 | _aVillard, Frederic | |
| 700 | 1 | _aMoreau, Robert J | |
| 700 | 1 | _aValeur, Eric | |
| 700 | 1 | _aPaulding, Stephanie C | |
| 700 | 1 | _aSchleeger, Simone | |
| 700 | 1 | _aSchipp, Kathrin | |
| 700 | 1 | _aLoup, Joachim | |
| 700 | 1 | _aAndrews, Lori | |
| 700 | 1 | _aSwale, Ryann | |
| 700 | 1 | _aRobinson, Michael | |
| 700 | 1 | _aFarady, Christopher J | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 28 _gno. 5 _gp. 906-909 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2018.01.064 _zAvailable from publisher's website |
| 999 |
_c28076587 _d28076587 |
||